Nursing homes drugging elders, faking records per audits

Source: marketwatch.com

TL;DR

The story at a glance

A MarketWatch opinion piece by Brett Arends calls out nursing homes for misusing antipsychotic drugs on elderly dementia residents to control behavior and faking records, based on recent HHS Office of Inspector General reports.[[3]](https://www.marketwatch.com/story/nursing-homes-are-drugging-your-parents-to-keep-them-docile-and-falsifying-medical-records-to-cover-it-up-be64f9f9)[[1]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriate-use-of-antipsychotic-drugs-poses-a-risk-to-residents) The reports reviewed 40 CMS inspections of nursing homes and found ongoing problems despite FDA warnings.[[1]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriate-use-of-antipsychotic-drugs-poses-a-risk-to-residents) This comes amid long-known concerns about chemical restraints in understaffed facilities.[[4]](https://www.marketwatch.com/story/nursing-homes-are-drugging-your-parents-to-keep-them-docile-and-falsifying-medical-records-to-cover-it-up-be64f9f9?gaa_at=eafs&gaa_n=AWEtsqe-vc7cLw9H02qrcDzNBNwenqPNjZTozf3h1CGBR2kjHIg1HvVmur9H&gaa_sig=bmUDzXlPifBuievostIr73O4UAIjt4KGPs9nf4JnYREYc5_tLsNqtwYWqI7FigDrcF1BdU0aGsnXQIa7wDmOhQ%3D%3D&gaa_ts=69d55c9e)

Key points

Details and context

The two HHS-OIG reports (OEI-02-23-00200 and OEI-02-23-00201), issued March 2026, analyzed 40 CMS surveys where nursing homes were cited for antipsychotic issues—these were not random but targeted cases.[[1]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriate-use-of-antipsychotic-drugs-poses-a-risk-to-residents)[[2]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriately-diagnosed-residents-with-schizophrenia-to-mask-the-misuse-of-antipsychotic-drugs) Antipsychotics like risperidone aren't FDA-approved for dementia but sedate users, acting as "chemical restraints" to ease staffing strains.[[1]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriate-use-of-antipsychotic-drugs-poses-a-risk-to-residents)

Schizophrenia diagnoses exempt residents from a key quality metric (long-stay antipsychotic use), which affects the five-star ratings families use to pick homes—leading to manipulated records for better scores.[[2]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriately-diagnosed-residents-with-schizophrenia-to-mask-the-misuse-of-antipsychotic-drugs)

Past efforts since 2012 cut average use, but problems persist in cited facilities; OIG urges CMS to target oversight, train directors/pharmacists, and inform families better.[[1]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriate-use-of-antipsychotic-drugs-poses-a-risk-to-residents)

Key quotes

"Nursing homes gave antipsychotic drugs to residents with dementia to manage their behavior for the benefit of staff, despite FDA’s warning that these drugs may increase the risk of death." – HHS-OIG report OEI-02-23-00200[[1]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriate-use-of-antipsychotic-drugs-poses-a-risk-to-residents)

"Nursing homes inappropriately diagnosed residents with schizophrenia to mask the nursing homes’ misuse of antipsychotic drugs and to artificially inflate their star ratings." – HHS-OIG report OEI-02-23-00201[[2]](https://oig.hhs.gov/reports/all/2026/nursing-homes-inappropriately-diagnosed-residents-with-schizophrenia-to-mask-the-misuse-of-antipsychotic-drugs)

Why it matters

Vulnerable elders in nursing homes face heightened death risks from unneeded sedatives, undermining trust in a system already strained by staffing shortages. Families choosing facilities via Medicare ratings get misled by inflated scores, while taxpayers fund improper Medicare claims. Watch for CMS responses to OIG recommendations and any new audits, though broad fixes remain uncertain.